ST
LUMO

Spot Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Spot Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$137K Buy
+1,496
New +$115K ﹤0.01% 2427
2016
Q2 		– Sell
-392
Closed -$48.6K – 3907
2016
Q1 		$64K Buy
392
+383
+4,256% +$77.6K ﹤0.01% 2741
2015
Q4 		$3K Sell
9
-1,546
-99% -$503K ﹤0.01% 3466
2015
Q3 		$502K Sell
1,555
-323
-17% -$142K ﹤0.01% 2052
2015
Q2 		$748K Buy
1,878
+1,000
+114% +$425K 0.01% 1829
2015
Q1 		$432K Buy
878
+874
+21,850% +$339K ﹤0.01% 2213
2014
Q4 		$1K Sell
4
-675
-99% -$201K ﹤0.01% 3910
2014
Q3 		$131K Sell
679
-16,261
-96% -$3.58M ﹤0.01% 3401
2014
Q2 		$4.05M Buy
+16,940
New +$3.44M 0.02% 1109
2014
Q1 		– Sell
-945
Closed -$289K – 4582
2013
Q4 		$187K Buy
+945
New +$168K ﹤0.01% 3053
2013
Q3 		– Sell
-1,112
Closed -$179K – 4492
2013
Q2 		$197K Buy
+1,112
New +$157K ﹤0.01% 3066

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Spot Trading's LUMO Position: Q3 2017 in Review

Spot Trading opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017: 1,496 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #2427 among its holdings. This is a return to the name: Spot Trading previously reported a position in LUMO as recently as Q1 2016.

Spot Trading first reported a position in LUMO in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.05M in Q2 2014. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • Spot Trading held 1,496 shares of Lumos Pharma, Inc. Common Stock worth $137K as of Q3 2017.
  • Lumos Pharma, Inc. Common Stock was a new Spot Trading position in Q3 2017.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2427 holding.
  • Spot Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 11 quarters since.
  • Spot Trading's Lumos Pharma, Inc. Common Stock position peaked at $4.05M in Q2 2014.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.